Literature DB >> 28087177

Lymphocytic myocarditis occurs with myocardial infarction and coincides with increased inflammation, hemorrhage and instability in coronary artery atherosclerotic plaques.

Linde Woudstra1, P Stefan Biesbroek2, Reindert W Emmens3, Stephane Heymans4, Lynda J Juffermans5, Albert C van Rossum5, Hans W M Niessen6, Paul A J Krijnen7.   

Abstract

OBJECTIVE: Although lymphocytic myocarditis (LM) clinically can mimic myocardial infarction (MI), they are regarded as distinct clinical entities. However, we observed a high prevalence (32%) of recent MI in patients diagnosed post-mortem with LM. To investigate if LM changes coronary atherosclerotic plaque, we analyzed in autopsied hearts the inflammatory infiltrate and stability in coronary atherosclerotic lesions in patients with LM and/or MI.
METHODS: The three main coronary arteries were isolated at autopsy of patients with LM, with MI of 3-6h old, with LM and MI of 3-6h old (LM+MI) and controls. In tissue sections of atherosclerotic plaque-containing coronary segments inflammatory infiltration, plaque stability, intraplaque hemorrhage and thrombi were determined via (immuno)histological criteria.
RESULTS: In tissue sections of those coronary segments the inflammatory infiltrate was found to be significantly increased in patients with LM, LM+MI and MI compared with controls. This inflammatory infiltrate consisted predominantly of macrophages and neutrophils in patients with only LM or MI, of lymphocytes in LM+MI and MI patients and of mast cells in LM+MI patients. Moreover, in LM+MI and MI patients this coincided with an increase of unstable plaques and thrombi. Finally, LM and especially MI and LM+MI patients showed significantly increased intraplaque hemorrhage.
CONCLUSIONS: This study demonstrates prevalent co-occurrence of LM with a very recent MI at autopsy. Moreover, LM was associated with remodeling and inflammation of atherosclerotic plaques indicative of plaque destabilization pointing to coronary spasm, suggesting that preexistent LM, or its causes, may facilitate the development of MI. Copyright Â
© 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coronary arteries; Inflammation; Lymphocytic myocarditis; Myocardial infarction; Plaque instability

Mesh:

Year:  2017        PMID: 28087177     DOI: 10.1016/j.ijcard.2017.01.052

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Lymphocytic myocarditis presenting as acute myocardial infarction: a case report and review of the literature.

Authors:  Zhiwei Huang; Guangxun Feng; Yan Liang
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

Review 2.  Infectious myocarditis: the role of the cardiac vasculature.

Authors:  Linde Woudstra; Lynda J M Juffermans; Albert C van Rossum; Hans W M Niessen; Paul A J Krijnen
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

3.  Tranexamic acid decreases rodent hemorrhagic shock-induced inflammation with mixed end-organ effects.

Authors:  Patrick F Walker; Anthony D Foster; Philip A Rothberg; Thomas A Davis; Matthew J Bradley
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

4.  Non-diagnostic autopsy findings in sudden unexplained death victims.

Authors:  Puriya Daniel Yazdanfard; Alex Hørby Christensen; Jacob Tfelt-Hansen; Henning Bundgaard; Bo Gregers Winkel
Journal:  BMC Cardiovasc Disord       Date:  2020-02-04       Impact factor: 2.298

5.  Protective effect of scutellarin on myocardial infarction induced by isoprenaline in rats.

Authors:  Haibo Huang; Qianqian Geng; Hong Yao; Zhenhuang Shen; Zhenhong Wu; Xiaoqing Miao; Peiying Shi
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699

6.  The effect of ginger (Zingiber officinale) feed on cardiac biomarker in medium-dose isoproterenol-induced myocardial toxicity.

Authors:  Alaba Olumide Ojo; Omowumi Hilda Ekomaye; Oluwabukunmi Marvelous Owoade; Olatunbosun Olumuyiwa Onaseso; Lawrence Dayo Adedayo; Olufemi Idowu Oluranti; Emmanuel Olusegun Timothy; Abiodun Ayoka
Journal:  Avicenna J Phytomed       Date:  2021 Jan-Feb
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.